Awards & recognition
Our first award was $25,000 from this FDA sponsored event held by Children's National Health System in San Jose, CA on September 24, 2017
Prapela was honored to be chosen as the best overall presentation given to over 200 attendees in Waltham, MA on October 27, 2017
In Helsinki Finland, on November 30, 2017 we won $75,000, the top prize in a field of 135 applicants from around the world.
On February 6, 2018 the NIH/NIDA announces Prapela a one of the winners in their "Start a Substance Use Disorder Startup" Challenge.
We were honored to be selected as one of the 2018 finalists in the 7th annual $200K M2D2 Challenge held in Lowell, MA
MassChallenge announced the selection of Prapela to its 2018 Cohort on May 23, 2018. A total of 1600 startups applied to MC in 2018.
Prapela was honored to be one of the few pediatric startups selected for financial support from the Hood Foundation on July 2, 2018
November 1, 2018 marks the day when Ohio's Third Frontier awarded Prapela $200,000 in the Ohio Opioid Technology Challenge - Challenge Phase
We were selected to this first-of-its-kind gathering of entrepreneurs, funders, experts, and mentors to shine a spotlight on early childhood innovations
At SXSW in Austin Texas, Prapela was awarded $25,000 from the Baylor College of Medicine in the FDA Pediatric Device Innovation Program
The National Institute on Drug Abuse (NIDA) awarded our pediatric biotechnology startup a $222,000 Phase I SBIR grant on March 19, 2019
iSPI is a group of health practitioners from more than a hundred institutions worldwide dedicated to improving the health of children through innovation.
Prapela wins $1,000,000 in the Ohio Opioid Technology Challenge - Product Phase on August 27, 2019 in Columbus, Ohio
On September 3, 2019 we received a"Milestone Achievement Program" award of $200,000 from the Massachusetts Life Sciences Center
The US Food & Drug Administration designated the Prapela bassinet pad for NOWS as a breakthrough medical device on October 4, 2019
Maine Technology Institute awarded Prapela $100,000 on April 29, 2020 to support our work to gain FDA clearance
Impacted by the pandemic, we were grateful to receive $100,000 from the Southern Maine Planning and Development Commission in October, 2020
We had so much fun being selected as a finalist on May 7, 2021, in this wonderful community-based competition to support startup companies
Prapela was awarded $2,500,000 on May 25, 2021 from the NIH/NIDA. The SBIR Phase II award funds a clinical study led by Tufts Medical Center
Prapela was recognized by Startups.us as one of Maine's best startups. Selection criteria included innovation, growth, management & impact.
On May 24, 2022, the prestigious FDA funded NCC-PDI program selected Prapela as a finalist for our efforts to improve the treatment of preterm apnea
